Biological Psychology & Pharmacotherapy
Subject 512-916 (2009)
Note: This is an archived Handbook entry from 2009. Search for this in the current handbook
| Credit Points: | 6.25 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Level: | 9 (Graduate/Postgraduate) | ||||||||||||
| Dates & Locations: | This subject has the following teaching availabilities in 2009: Semester 2, - Taught on campus.
Timetable can be viewed here. For information about these dates, click here. | ||||||||||||
| Time Commitment: | Contact Hours: 1.5 hours of lectures/seminars per week for 12 weeks. Estimated Total Time Commitment: 54 hours Total Time Commitment: Not available | ||||||||||||
| Prerequisites: |
PSYC00029 Graduate Research Methods PSYC00030 Introduction Psychological Assessment PSYC00031 Introduction to Psychopathology | ||||||||||||
| Corequisites: | None | ||||||||||||
| Recommended Background Knowledge: | None | ||||||||||||
| Non Allowed Subjects: | None | ||||||||||||
| Core Participation Requirements: |
For the purposes of considering request for Reasonable Adjustments under the Disability Standards for Education (Cwth 2005), and Student Support and Engagement Policy, academic requirements for this subject are articulated in the Subject Overview, Learning Outcomes, Assessment and Generic Skills sections of this entry. It is University policy to take all reasonable steps to minimise the impact of disability upon academic study, and reasonable adjustments will be made to enhance a student's participation in the University's programs. Students who feel their disability may impact on meeting the requirements of this subject are encouraged to discuss this matter with a Faculty Student Adviser and Student Equity and Disability Support: http://services.unimelb.edu.au/disability |
Coordinator
Prof Nick AllenContact
Associate Professor Michael Saling
Dr Trevor Norman
| Subject Overview: |
The disorders covered in this subject will include affective disorders, schizophrenia, stress and anxiety disorders, substance abuse disorders and disorders of cognitive function. The biological bases of these disorders will be discussed by outlining the contribution of evolutionary, genetic, neuroanatomical, and neurochemical factors, as well as how these factors interact with the psychosocial environment. Other topics that will be covered include psychopharmacological treatments of these disorders (ie. antipsychotics, antidepressants, mood-stabilisers, cognitive enhancing drugs and anti-depressants) and their mechanism of action and side effect profile. |
|---|---|
| Objectives: | Students will be given the opportunity to develop knowledge of the biological basis of psychiatric disorders and of the relevant neurochemical and neurophysiological systems underpinning those disorders. In addition students will learn about he psychopharmacological treatments for these disorders including their mechanism of action of side effect profile. |
| Assessment: |
A mid-semester essay of 1500 words (60% of assessment) An end-of-semester 60 minute multiple choice test (40% of assessment). |
| Prescribed Texts: | None |
| Breadth Options: | This subject is not available as a breadth subject. |
| Fees Information: | Subject EFTSL, Level, Discipline & Census Date |
| Generic Skills: |
Written skills Analytic and information integration skills |
| Related Course(s): |
Master of Psychology (Clinical Child) Master of Psychology (Clinical) Master of Psychology(Clinical Psychology)/Doctor of Philosophy Master of Psychology/PhD (Clinical Child) |
Download PDF version.